Article Title,Year,Volume,Issue,Page Range,Author
Suicide risk analysis among patients assigned to psychotropics and placebo,2006,39,1,6-14,Khan
Toward a nosology of human aggressive behavior,1993,29,1,57-63,Eichelman
The use of anticonvulsants in aggression and violence,1993,29,1,75-81,Barratt
Proceedings: Maturational lag in central nervous system development as a partial explanation of episodic violent behavior,1974,10,4,63-64,Monroe
Chronic phencyclidine (PCP) abuse: a psychiatric perspective--Part I: General aspects and violence,1980,16,4,70-72,Fauman
Role of the serotonergic system in the postmortem analysis of suicide,1986,22,3,735-740,Mann
Genetic factors in suicide,1986,22,3,666-668,Roy
Suicide and adrenocortical function,1986,22,3,650-655,Mann
The suicide assessment scale: a scale evaluating change in suicidal behavior,1986,22,1,200-205,Stanley
Aminergic receptor binding correlates of suicide: methodological issues,1986,22,3,741-743,Mann
Postmortem serotonergic and adrenergic receptor binding to frontal cortex: correlations with suicide,1986,22,3,647-649,Mann
Suicidal potential in depression: focus on CSF monoamine and purine metabolites,1986,22,3,656-660,Agren
(Auto)aggression and CSF 5-HIAA in depression and schizophrenia,1986,22,3,669-673,van Praag
Monoamines glucose metabolism suicidal and aggressive behaviors,1986,22,3,661-665,Roy
The effects of fenfluramine on suicidal behavior,1986,22,1,155-159,Jain
Melatonin levels are reduced in the pineal glands of suicide victims,1988,24,3,484-488,Stanley
Rationale for clinical trials of opiate antagonists in treating patients with personality disorders and self-injurious behavior,1989,25,4,556-563,Schulz
Neurochemical studies of violent and nonviolent suicide,1989,25,3,407-413,Marzuk
The differential diagnosis of self-injurious behavior in mentally retarded people,1989,25,3,358-363,Gualtieri
Dopamine deficiency in self-injurious behavior,1989,25,3,353-357,Breese
Dopaminergic mechanisms in self-inflicting biting behavior,1989,25,3,349-352,Goldstein
Lithium and propranolol in aggression and self-injurious behavior in the mentally retarded,1989,25,3,372-375,Luchins
Pharmacotherapy for self-injurious behavior: preliminary tests of the D1 hypothesis,1989,25,3,364-371,Schroeder
A double-blind placebo-controlled study of adjunctive nadolol in the management of violent psychiatric patients,1990,26,3,367-371,Alpert
Akathisia and violence,1990,26,1,115-117,Volavka
Self-injurious behavior in the developmentally disabled: pharmacologic treatment,1992,28,4,439-449,Loschen
Self-injurious behavior in the developmentally disabled: assessment techniques,1992,28,4,433-438,Loschen
Fluoxetine trial in suicidal depressed alcoholics,1993,29,2,195-199,Cornelius
The Children's Depression Inventory (CDI),1985,21,4,995-998,Kovacs
Pharmacology of kava. 2,1967,4,3,11-12,Buckley
Piper methysticium (kava). The function of kava in modern Samoan culture,1967,4,3,9,Holmes
Ethnographical aspects of kava,1967,4,3,12,Ford
The psychopharmacology of aggression: toward a new day,1993,29,1,65-73,Gordon
Oxytocin and complex social behavior: species comparisons,1993,29,3,409-414,Carter
Self-injurious behavior and serotonin in Prader-Willi syndrome,1994,30,2,245-250,Hellings
The Overt Aggression Scale in a study of lithium in aggressive conduct disorder,1994,30,2,215-218,Malone
Placebo response in aggressive children with conduct disorder,1994,30,2,209-213,Campbell
The interaction of ethnicity sociocultural factors and gender in clinical psychopharmacology,1996,32,2,283-289,Dawkins
Why do persons with bipolar disorder stop their medication?,2010,43,3,5-14,Blow
Brief report: paroxetine in younger and adult individuals at high risk for suicide,2006,39,1,31-37,Bauer
Unraveling the diagnostic clues of depression and GAD: the primary care challenge,2002,36,Suppl 2,150-157,Lee
The 5-HT1B receptor: behavioral implications,2001,35,4,170-185,Clark
Buspirone challenge: preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behavior in humans,1990,26,3,393-405,Siever
Diazepam impairs performance in normal elderly subjects,1984,20,1,137-139,Pomara
Proceedings: Behavioral and EEG changes in the amphetamine model of psychosis,1974,10,3,13-14,Ellinwood
Proceedings: Drinking as a response to power needs in man,1974,10,4,5-6,McClelland
Manual for the determination of narcotics and dangerous drugs in the urine,1966,3,3,18-42,Hine
A practical application of thin-layer chromatography in the detection of narcotic drugs in the urine,1966,3,4,34-36,Kokoski
Laboratory experience in drug abuse control,1966,3,4,30-33,Davidow
Requirements and evaluations of narcotics tests,1966,3,4,27-29,Mannering
Workshop on the detection and control of abuse of narcotics barbiturates and amphetamines; San Juan Puerto Rico December 13-15 1965,1966,3,4,21-26,Leonard
Pharmaceutical decisionmaking: pharmacoepidemiology or pharmacoeconomics--who's in the driver's seat?,1995,31,4,735-744,Zito
Amino acid balance and aggression in mice,1978,14,1,69,Thurmond
Animal model for study of hyperkinesis and aggression,1978,14,1,68,Scott
Psychomotor performance following the long-term use of benzodiazepines,1985,21,1,93-96,Geller
Tardive dyskinesia and depressive symptoms in schizophrenics,1985,21,1,130-135,Craig
Psychomotor changes during the initial day of benzodiazepine medication [proceedings],1979,15,2,39-40,McGough
The differential effects of viloxazine and imipramine on performance tests: their relationship to behavioural toxicity,1980,16,3,57-58,Khan
Visual perception process in amphetamine psychosis and schizophrenia,1986,22,3,768-773,Kojima
Psychotic manifestations in amphetamine abuse--experimental study on the mechanism of psychotic recurrence,1986,22,3,763-767,Ando
Reverse tolerance to the ambulation-increasing effect of methamphetamine in mice as an animal model of amphetamine-psychosis,1986,22,3,757-762,Tadokoro
Acute exacerbation of methamphetamine psychosis and lasting dopaminergic supersensitivity--a clinical survey,1986,22,3,751-756,Sato
Interactions of alcohol and drugs of abuse,1986,22,3,717-721,Braude
Physiological and performance responses to diazepam: two types of effects,1986,22,2,439-443,Hoehn-Saric
Psychiatric patients' comprehension of consent information,1987,23,3,375-378,Stanley
Phencyclidine revisited [proceedings],1980,16,4,85-86,Luby
Chronic phenycyclidine (PCP) abuse: a psychiatric perspective--Part II: Psychosis [proceedings],1980,16,4,72-73,Fauman
A clinical approach to the treatment of phencyclidine (PCP) abuse [proceedings],1980,16,4,67-70,Smith
Depression in children: concentration-dependent CNS toxicity of tricyclic antidepressants,1988,24,1,140-142,Weller
Evaluation of drug-related movement disorders in the aged,1988,24,4,603-607,Schooler
Asenapine for the control of physical aggression: a prospective naturalist pilot study,2017,47,1,27-32,El-Mallakh
A review of psychopharmacological interventions post-disaster to prevent psychiatric sequelae,2017,47,1,8-26,Math
The addition of amphetamine to potentially sedating medication regimens: an exploratory investigation of the impact upon reaction time and sustained attention,2017,47,2,22-35,Price
Delayed-onset toxicity in an adolescent case following attempted suicide with an overdose of paliperidone intake,2019,49,2,46-51,Erkuran
Cannabis use and its association with psychological disorders,2020,50,2,56-67,Kaye
Adverse effects of recreational and medical cannabis,2021,51,1,94-109,Kaye
A pilot study to explore the effect of long acting injectable antipsychotics on aggression,2024,54,1,18-24,Beck
Characteristics of Inpatients Prescribed Dopamine Receptor Blocking Agents,2021,51,4,51-64,Schwartz
Antidepressant overdoses and resultant emergency department services: the impact of SSRIs,1997,33,4,667-670,Steele
The evaluation of women with schizophrenia,1998,34,3,271-277,Goldstein
Does isotretinoin cause depression and suicide?,2003,37,1,64-78,Bremner
Overview of the safety of citalopram,2003,37,1,96-121,Nemeroff
Successful Resolution of Prominent Somatic Delusions Following Bi-temporal Electroconvulsive Therapy in a patient with Treatment-Resistant Schizoaffective Disorder,2019,49,2,52-56,Birur
Clinical pharmacokinetics of tricyclic antidepressant overdose,1991,27,4,541-550,Jarvis